9.57 USD
↗ 0.76 (8.63%)AT CLOSE (03:59 PM EDT)
Climb Bio, Inc. Common Stock
CLYMNASDAQ • USD
9.85
↗ 0.28 (2.95%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
9.85
↗ 0.28 (2.95%)
Market: CLOSED
Shares of Climb Bio, Inc. Common Stock (CLYM) are trading at $9.56. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, CLYM appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 27, 2026.
Open?$9.09
High?$10.15
Low?$8.82
Prev. Close?$8.81
Volume?3.9M
Avg. Volume?1.4M
VWAP?$9.56
Rel. Volume?2.75x
Bid / Ask
Bid?$9.50 × 1.0K
Ask?$10.20 × 1.0K
Spread?$0.70
Midpoint?$9.85
Valuation & Ratios
Market Cap?549.7M
Shares Out?57.4M
Float?38.3M
Float %?66.7%
P/E Ratio?N/A
P/B Ratio?2.29
EPS?-$1.00
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Themes
Employees
29
Market Cap
506.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-08-10
Address
20 WILLIAM STREET
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?47.09Safe
Confidence?41%Low
Short InterestSqueeze Risk
Short % of Float?25.57%Squeeze Risk
Short Interest?9.8M
Days to Cover?10.3
Free Float38.3M
Avg Daily Volume946.2K
Settlement Date2026-10-15
Financial Health
Current Ratio?31.45Strong
Quick Ratio?31.45Strong
Cash Ratio?7.43Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.29CHEAP▾
Peers100
S&P68
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-7.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-24.1%WEAK▾
S&P7
ROA?-23.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-53068000
Enterprise Value?$505.6M
Fundamentals ratios updated end of day